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ABSTRACT
We are just beginning to unravel the myriad of inter-
actions in which non-coding RNAs participate. The
intricate RNA interactome is the foundation of many
biological processes, including bacterial virulence
and human disease, and represents unexploited re-
sources for the development of potential therapeutic
interventions. However, identifying specific associa-
tions of a given RNA from the multitude of possible
binding partners within the cell requires robust high-
throughput systems for their rapid screening. Here,
we present the first demonstration of functional-RNA
arrays as a novel platform technology designed for
the study of such interactions using immobilized,
active RNAs. We have generated high-density RNA
arrays by an innovative method involving surface-
capture of in vitro transcribed RNAs. This approach
has significant advantages over existing technolo-
gies, particularly in its versatility in regards to bind-
ing partner character. Indeed, proof-of-principle ap-
plication of RNA arrays to both RNA–small molecule
and RNA–RNA pairings is demonstrated, highlight-
ing their potential as a platform technology for map-
ping RNA-based networks and for pharmaceutical
screening. Furthermore, the simplicity of the method
supports greater user-accessibility over currently
available technologies. We anticipate that functional-
RNA arrays will find broad utility in the expanding
field of RNA characterization.
INTRODUCTION
Understanding themolecular interactions that underlie bio-
logical processes is a fundamental aspect of basic biological
research and pharmaceutical drug development. The last
two decades have seen the development of high-throughput
gene expression profiling technologies, including DNA mi-
croarrays and RNA-sequencing (RNA-seq), leading to an
increased focus on RNA and its interacting partners. In-
deed, increasing numbers of RNA–protein (1), RNA–small
molecule (e.g. riboswitches (2)) and RNA–RNA interac-
tions (e.g. bacterial small regulatory RNAs (sRNAs; (3))
and eukaryotic microRNAs (miRNA; (4)) are being identi-
fied. Of particular interest are the noncoding RNAs (ncR-
NAs; (5)), such as riboswitches, sRNAs and miRNAs.With
emerging roles in bacterial virulence (sRNAs; (6)) andmany
cancers (miRNAs; (7)), ncRNAs are believed to represent
an, as yet, largely untapped resource in the search for novel
antimicrobial and/or therapeutic strategies (8–10). In or-
der to unravel the network of interactions in which ncR-
NAs participate, and realize their potential as pharma-
ceutical targets, there is a requirement for accessible high-
throughput RNA-interaction analysis techniques.
Some progress has been made towards the development
of high-density RNA surfaces that are suitable for probing
RNA–protein interactions. The Greenleaf (11,12) and Lis
(13,14) groups have both utilized the Illumina Next Gen-
eration Sequencing platform, capturing transcribed RNAs
via a template DNA–protein complex. However, a disad-
vantage of this method is the complexity of the surface.
In particular, the presence of the template DNA precludes
the application of this technique to primarily sequence-
dependent nucleic acid–RNA interactions typical of most
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ncRNAs. In contrast, the Smith group (15,16) have em-
ployed photolithography, combined with chemical DNA
and RNA synthesis, to prime enzymatic synthesis of RNA.
The DNA template is removed by DNase treatment result-
ing in a much simpler surface. However, the use of chemical
nucleic acid synthesis limits the length of the RNAs that can
be produced. To date, arrays of RNAs only≤33 nucleotides
in length have been generated using this method, which is
much shorter than many functional RNAs of biological in-
terest. Furthermore, regardless of the production method,
application has been restricted to RNA–protein interac-
tions. Neither of the two approaches have been applied to
RNA–small molecule or RNA–RNA interactions. There-
fore, while high-densityRNA surfaces clearly have potential
as a high-throughput RNA-interaction analysis technique,
there are also limitations inherent to the currently avail-
able production methodologies. Consequently, the need for
a high-density functional-RNA platform technology that is
capable of broad utility within the RNA field remains.
A major drawback of the existing technologies is the re-
liance on specialist equipment, not always available to the
everyday RNA researcher. Here, we present a simple, inno-
vative method for the production of the first high-density
functional-RNA arrays, programmed by DNA arrays, that
would be suitable for high-throughput analysis of RNA in-
teractions. We demonstrate proof-of-principle application
of these arrays to both RNA–small molecule and RNA–
RNA interactions, exemplifying the unique capability of
our RNA array platform with regard to the range of bind-
ing partners that can be investigated. We highlight the po-
tential utility of RNA arrays as a platform technology in
the development of novel antimicrobial strategies andRNA
therapies.
MATERIALS AND METHODS
Design of DNA in vitro transcription templates
All DNA in vitro transcription templates for preparation
of DNA template arrays contained a biotinylated 5′ linker
(5′–biotin–ctc gag–3′) to facilitate surface-immobilization,
immediately followed by a T7 promoter (5′–taa tac gac tca
cta tag–3′) and then the sequence encoding the RNA of in-
terest (see Supplementary Table S1 for sequences). DNA
templates encoding RNA–aptamer conjugates shared the
general design shown in Figure 1A, which includes an ad-
ditional internal linker sequence (see Supplementary Ta-
ble S2 for sequences) followed by an aptamer sequence (to-
bramycin aptamer: 5′–ggc tta gta tag cga ggt tta gct aca
ctc gtc gtg agc c–3′; streptavidin aptamer: 5′–acc gac cag
aat cat gca agt gcg taa gat agt cgc ggg ccg gg–3′) 3′ to the
RNA of interest. The predicted secondary structure of each
of theRNA-linker-aptamer conjugates was calculated using
Mfold (17) and RNAfold (18) to check that both the RNA
of interest and the aptamer were likely to adopt their native
structure (see Supplementary Figure S1 as an example).
Preparation of DNA in vitro transcription templates
Initially, non-labelled PCR templates, lacking the biotiny-
lated 5′ linker, were prepared for both unconjugated RNAs
and the RNA–aptamer conjugates. PCR templates for un-
conjugated rpoS and the rpoS–streptavidin aptamer con-
jugate were generated by standard PCR using the primers
listed in Supplementary Table S3 and plasmid rpoS-Blunt
II TOPO (19) as the template. The PCR template for the
unconjugated malachite green (MG) aptamer was prepared
by annealing two complementary single-stranded oligonu-
cleotides (see Supplementary Table S3 for the sequences).
All other PCR templates were prepared by gene synthesis
using overlapping primers (20; primers are listed in Supple-
mentary Table S3).
DNA in vitro transcription templates, containing the bi-
otinylated 5′ linker sequence required for preparing the
DNA template arrays, were generated by standard PCR us-
ing the PCR templates prepared above, sense primer: 5′–
biotin–ctc gag taa tac gac tca cta tag g–3′ and the appro-
priate antisense primer from Supplementary Table S4.
5′ biotin- and 3′ fluorescently-labelled DNA in vitro tran-
scription templates, required for the visualization of the
unconjugated MicA and MicA–streptavidin aptamer con-
jugate (MicAsa) DNA template array, were generated by
standard PCR using theMicA/MicAsa PCR templates pre-
pared above, sense primer: 5′–biotin–ctc gag taa tac gac tca
cta tag g–3′ and antisense primers 5′–Alexa647–aaa agg cca
ctc gtg agt–3′ or 5′–Alexa647–gca tgc atc ccg gcc cgc gac tat
ctt acg ca–3′ for MicA and MicAsa, respectively.
All PCR and in vitro transcription templates were puri-
fied using a standard spin column-based PCR-clean-up kit
and their size was confirmed by agarose gel electrophoresis.
Preparation of streptavidin surfaces forDNA template arrays
For low-density surfaces, NHS-activated microarray slides
(Nexterion H, Schott) were spotted with 10 l aliquots
of 16.7 M (1 mg/ml) streptavidin in phosphate-buffered
saline (PBS; pH 7.4). For high-density surfaces, NHS-
activated slides were coated with 90 l 1M streptavidin
in PBS and covered with a LifterSlip (Thermo Fisher Scien-
tific). Spotted or coated slides were incubated at 37◦C for 1 h
in a humidified chamber.Where present, LifterSlips were re-
moved and slides were washed, with rocking, once for 5 min
with 45 ml PBS containing 0.05% (v/v) Tween 20 (PBS-T),
once for 5 min with 45ml PBS and once for 5 min with 45ml
H2O (wash-cycle A). They were then submerged in 45 ml 50
mMethanolamine–HCl pH 8.5 and incubated at room tem-
perature for 30 min, with rocking, to block unreacted NHS
functional groups.Wash-cycle Awas repeated and the slides
were dried by centrifugation at 500 × g for 5 min at room
temperature.
Preparation of DNA template arrays
For low-density arrays, between 0.2 l and 10 l of 200
nM 5′ biotinylated DNA template in PBS was manually
pipetted onto the streptavidin on the prepared streptavidin-
spotted slides. For high-density surfaces, an automated ar-
rayer (Genetix Qarray2) fitted with a 200 m pin-head was
used to spot 200 nM 5′ biotinylated DNA template onto
prepared streptavidin-coated slides at the spot separations
indicated in the Figure legends. The DNA-spotted slides
were incubated at 20◦C and 50% relative humidity for 30
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min, washed using wash-cycle A and dried by centrifuga-
tion at 500 × g for 5 min at room temperature.
DNA-template arrays containing 3′ fluorescently-
labelled MicA–Alexa647 and MicAsa–Alexa647 in vitro
transcription templates were visualized at 670 nm, follow-
ing excitation at 650 nm, using a microarray slide scanner
(aQuire, Genetix or Axon GenePix 4300A, Molecular
Devices).
Preparation of streptavidin RNA capture surfaces
Streptavidin surfaces, for use asRNA capture surfaces, were
prepared as described above for DNA template arrays, ex-
cept that streptavidin was used at a concentration of 16.7
M (1 mg/ml) in PBS to produce coated (high-density
RNA capture) surfaces.
Preparation of tobramycin RNA capture surfaces
Spotted (low-density) tobramycin RNA capture surfaces
were prepared as described above for streptavidin surfaces,
except that 5 mM tobramycin in PBS was used instead of
streptavidin.
Production of functional-RNA arrays
The DNA template array, RNA capture surface and in vitro
transcription mixture (1X Reaction Buffer (MEGAscript
T7 Transcription Kit, Thermo Fisher Scientific)), 1X En-
zymeMix (MEGAscript T7 TranscriptionKit) and 0.5 mM
of ATP, CTP, GTP and UTP) were assembled into a ‘sand-
wich’ arrangement (Figure 1B), as described below. Two
small pieces of Parafilm were placed on top of the RNA
capture surface, at each of the short ends of the slide, to act
as spacers and prevent the DNA template array and RNA
capture surface from coming into direct contact. 150 l in
vitro transcription mixture was manually pipetted onto the
RNA capture surface and theDNA template array was gen-
tly lowered to complete the ‘sandwich’ assembly. This was
incubated at 37◦C in a humidified chamber for 90 minutes.
Following transcription, the slides were separated and the
RNA capture surface, now a functional-RNA array, was
washed using wash-cycle A and dried by centrifugation at
500 × g for 5 min at room temperature.
For preparation of Cy3/Cy5-labelled RNA arrays, the in
vitro transcription mix was supplemented with 0.05 mM
Cy3/Cy5-UTP (GE Healthcare) and the transcription re-
action was performed in the dark. Arrays containing Cy3-
or Cy5-labelled RNAs were visualized at 570 or 670 nm,
following excitation at 550 or 650 nm, respectively, using a
microarray slide scanner.
Preparation of Cy3/Cy5-labelled RNA probes
Internally Cy3/Cy5-labelled ompA and Qrr1 RNA probes
were generated by in vitro transcription. The relevant PCR
template (prepared above) was used as the template in an in
vitro transcription reaction using theMEGAscript T7 Tran-
scription Kit supplemented with 0.05 mM Cy3/Cy5-UTP.
The probes were purified using the MEGAclear Transcrip-
tion Clean-up Kit (Thermo Fisher Scientific).
Probing functional-RNA arrays
For single probes, 90 l of 30 nM–3 M (see Figure leg-
ends for experiment-specific details) labelled RNA probe or
20 Mmalachite green (Sigma) in hybridization buffer (40
mMTris (pH 7.8), 6 mMMgCl2, 20 mMNaCl) were pipet-
ted over the functional-RNA array. This was covered with
a LifterSlip and incubated at 20◦C, in a humidified cham-
ber, in the dark for 16 h, unless stated otherwise. The Lifter-
Slip was removed and the probed array was washed with 45
ml hybridization buffer for 1 min and 45 ml water for 10
s (wash-cycle B) before being dried by centrifugation at 500
× g for 5 min at room temperature. Simultaneous probing
was carried out as described for single probes using con-
centrations of 3 M for each individual RNA probe and 20
M for malachite green. Probed arrays were visualized at
570 nm (Cy3-labelled RNA probes) and/or 670 nm (Cy5-
labelled RNA probes and malachite green), following exci-
tation at 550 nm and/or 650 nm, respectively, using a mi-
croarray scanner.
RESULTS
Strategy for the production of functional-RNA arrays
Our functional-RNA array production method involves
the surface-capture of in vitro transcribed RNAs. A sur-
face consisting of an array of immobilized double-stranded-
DNA in vitro transcription templates is positioned opposite
to an RNA capture surface, in a ‘sandwich’ arrangement,
with the two surfaces connected by a solution of in vitro
transcription reagents (Figure 1B). To enable the surface-
capture of the RNA, each in vitro transcription template en-
codes anRNAaptamer 3′ to theRNAof interest (Figure 1).
Following transcription, the aptamer facilitates tethering of
the RNA to a capture surface coated with the cognate lig-
and. The use of RNA aptamers, which rely on adoption of
the correct structure for their activity, serves as an internal
control for correct folding of the RNA. Furthermore, the 3′
location of the aptamer ensures that only full-length RNAs
are immobilized. The physical separation of the DNA tem-
plate array and the RNA capture surface means that RNA
is the only nucleic acid present on the resulting functional-
RNA array. This array can then be probed with labelled
binding partners (Figure 1B). With each individual spot
on the DNA template array capable of encoding a differ-
ent RNA (e.g. different sequence, different length, differ-
ent function), it is possible to generate a diverse functional-
RNA array suitable for use as a high-throughput platform
for RNA-interaction analysis.
Proof-of-principle functional-RNA array production and ap-
plications
Initial proof-of-concept studies to demonstrate (i) surface-
capture of in vitro transcribed RNAs by RNA aptamers, (ii)
functionality of the RNAs on a generated RNA array and
(iii) generation of multi-RNA arrays, were performed using
manually spotted, low-density, DNA template arrays.
RNA aptamers with nanomolar affinity for small-
molecules (e.g. the aminoglycoside tobramycin (21–23)) or
proteins (e.g. streptavidin (24)) have been used previously
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Figure 1. Overview of functional-RNA array production. (A) The general design of the DNA in vitro transcription templates. From 5′ to 3′ there is: a short,
biotinylated linker (to facilitate surface-immobilization of the DNA), a T7 promoter, sequence encoding the RNA of interest, a second linker (to separate
the RNA of interest and the RNA aptamer) and sequence encoding an RNA aptamer (to facilitate RNA-capture). (B) A schematic representation of the
‘sandwich’ assembly and method used to produce the RNA array. A DNA in vitro transcription template array slide is positioned facing an RNA capture
slide. Thin spacers are used to physically separate the surfaces. A solution of in vitro transcription reagents is inserted between the two surfaces and RNA
transcription-capture proceeds for 90 min at 37◦C to generate a functional-RNA array. This RNA array can then be used as a platform for investigating
RNA-based interactions, e.g. probing with labelled binding partners.
as affinity purification tools (24,25), suggesting that they
are an effective means to tether RNA to a solid support.
Both tobramycin and streptavidin are commercially avail-
able and can be surface-immobilized using standard amine-
coupling chemistry to produce the RNA capture surface.
Tobramycin, as a small-molecule, would in theory result in
a simpler surface in the final RNA array than streptavidin,
a protein. Therefore, we first decided to evaluate the use of
tobramycin and the tobramycin aptamer.
DNA template arrays were prepared encoding a variety
of RNA–tobramycin aptamer (RNAtob) conjugates and the
corresponding unconjugated RNAs. The RNAs of inter-
est included three bacterial sRNAs and the 5′ UTR of a
bacterial mRNA. Following transcription using the ‘sand-
wich’ arrangement described in Figure 1B, the RNAtob con-
jugates were preferentially captured on a tobramycin cap-
ture surface relative to unconjugated RNAs (Supplemen-
tary Figure S2A). However, we also observed non-specific
binding of unconjugated RNAs, the extent of which was
RNA-dependent (Supplementary Figure S2A).
Due to the non-specific binding of RNA to the to-
bramycin surface, we next decided to evaluate the use of
the streptavidin aptamer for RNA-capture. As above, DNA
template arrays were prepared encoding a variety of RNA–
streptavidin aptamer (RNAsa) conjugates and the corre-
sponding unconjugated RNAs. In this case, the RNAs of
interest included bacterial sRNAs, the 5′ UTRs of bacte-
rial mRNAs, and a synthetic RNA aptamer. As shown in
Supplementary Figure S2B, following transcription, only
the RNAsa conjugates were present on the generated RNA
array, the nonconjugated RNAs were not captured. There
was no evidence of non-specific binding of RNA to the cap-
ture surface. Therefore, we decided to focus our efforts on
RNAsa conjugates.
Having successfully demonstrated the surface-capture of
RNA via RNA aptamers we next wanted to demonstrate
functionality of the captured RNAs. We selected the well-
characterized sRNA MicA–ompA mRNA interaction (26;
Supplementary Figure S3A), as an example of an RNA–
RNA interaction. MicA sRNA regulates the essential gene
ompA by binding to the 5′ untranslated region (5′ UTR)
of ompA mRNA, inhibiting translation and targeting the
RNA for degradation (26–28). The MicA–ompA interac-
tion relies both on the primary RNA sequence of the MicA
and ompARNAs and on their secondary structures, namely
the accessibility of specific regions (26). A low-density RNA
array ofMicAsa was generated and probed with ompA (Fig-
ure 2). As shown in Figure 2B the ompA probe binds to the
MicAsa RNA array suggesting that the captured-RNA is
functional.
The simple functional-RNA arrays described above have
only contained a single RNA species. We next wanted to
demonstrate that multi-RNA arrays could be produced
using our method. A low-density RNA array of MicAsa
sRNA, hapRsa (an mRNA involved in virulence of Vibrio
cholera (29)) and malachite green aptamer (MGsa, a syn-
thetic RNA aptamer), was prepared (Figure 3A). The RNA
array was probed with the triphenylmethane dye, malachite
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Figure 2. Production of a low-density functional MicAsa RNA array. (A)
Generation of a Cy3-labelled MicAsa RNA array using a DNA template
array of Alexa647-labelled MicA and MicAsa. (B) A non-labelled MicAsa
RNA array (generated as in (A) but without labelling) probed with Cy5-
labelled ompA.
green (Figure 3B). The specific binding of malachite green
to only MGsa indicates that a multi-RNA array has been
successfully probed. Furthermore, it demonstrates the func-
tionality of the capturedMGsa RNA and application of the
functional-RNA array platform to RNA–small molecule
interactions.
Production of a high-density single-RNA array
Our initial validation experiments were carried out using
DNA template arrays generated by manual spotting of
the DNA in vitro transcription templates onto glass slides.
Spotting of 10 l DNA template produces spots of ∼8 mm
diameter, allowing for a density of four templates per stan-
dard 25 × 75 mm glass slide. By reducing the spotting vol-
ume to 0.2 l, spots of ∼2 mm diameter were produced
and a density of 24 templates per slide was achieved. These
Figure 3. Production of a low-density multi-RNA array. (A) Generation
of a Cy3-labelledMicAsa, hapRsa andMGsa RNA array (i) Schematic lay-
out of a DNA template array of MicA, MicAsa, hapR, hapRsa, MG and
MGsa. (ii) Cy3-labelled RNA array generated from the DNA template ar-
ray following in vitro transcription.(B) Probing a low-density multi-RNA
array with malachite green. (i) Schematic representation of the middle row
of a non-labelled RNA array generated using the DNA template array in
A(i). (ii) As in B(i) following probing with malachite green. (iii) A non-
labelled MicAsa, hapRsa andMGsa RNA array (i) (generated as in (A) but
without labelling) probed with malachite green. The RNA array images
have been mirror imaged so that the spot positions correspond to those
shown in the schematics of the DNA template array.
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Figure 4. Production of a high-density MicAsa RNA array. (A) Prepa-
ration of a high-density DNA template array of MicA and MicAsa. (i)
Schematic layout of a single 6 × 6 grid with alternating rows of MicA
and MicAsa templates. (ii) A single 6 × 6 grid of a DNA template array
of Alexa647-labelled MicA and MicAsa. Individual spots were separated
by 750 m. (iii) The entire DNA template array of 21 repeating 6× 6 grids
as shown in (ii). (B) Production of a high-densityMicAsa RNA array from
the DNA template array described in (A). (i) Schematic of the expected
layout of a single grid of the MicAsa RNA array. (ii) A single grid of the
Cy3-labelled MicAsa RNA array. (iii) The entire MicAsa RNA array of 21
repeating grids as shown in (ii). The RNA array images have been mir-
ror imaged so that the spot positions correspond to those shown in the
schematics of the DNA template array.
low- to medium-density arrays may be useful for address-
ing direct mechanistic questions as part of a basic research
project. However, much higher density arrays would be re-
quired for most pharmaceutical applications.
To improve the density of the functional-RNAarray plat-
form we decided to use an automated arrayer to generate
the DNA template arrays.We prepared aDNA template ar-
ray of 21 identical 6 × 6 grids of alternating rows of MicA
andMicAsa in vitro transcription templates (756 spots in to-
tal) (Figure 4A). This was used to produce a high-density
MicAsa array (378 spots) (Figure 4B). The spots of cap-
turedMicAsa RNAwere observed to have an approximately
Gaussian profile, presumably resulting from the lateral dif-
fusion of the newly-transcribed RNA from its template
DNA spot, before its capture by a streptavidin molecule
on the capture surface (Supplementary Figure S4). Fur-
ther analysis revealed that the 756-spot DNA template ar-
ray contained individual spots of 76.3 ± 8.2 m full width
at half-maximum (FWHM) (Supplementary Figure S4A)
and generated a 378-spot RNA array with spots of 137.1
± 5.9 mFWHM (Supplementary Figure S4B). Therefore,
the chosen spot-density for the high-density DNA template
array was more than sufficient to maintain effective sep-
aration of the corresponding RNA spots and generate a
high-density RNA array. There is the potential to gener-
ate higher-density RNA arrays through optimization of the
DNA template array density, reaction conditions, etc. How-
ever, this was not the main goal of this work and has not
been pursued further.
Figure 5. Production and screening of high-density multi-RNA arrays
with single probes. (A) A DNA template array of MicAsa, MicA, ompAsa,
hapRsa, ilvCsa, ilVEsa, hisGsa, ureAsa and MGsa templates (left: schematic
of a single-field) was used to generate an eight-RNA array of MicAsa,
ompAsa, hapRsa, ilvCsa, ilVEsa, hisGsa, ureAsa and MGsa that was probed
with 3 M Cy3-labelled ompA (right). (B) A DNA template array of
MicAsa, MicA, ompAsa, hapRsa, ilvCsa, ilVEsa, hisGsa, ureAsa and MGsa
templates (left: schematic of a single-field) was used to generate an eight-
RNA array of MicAsa, ompAsa, hapRsa, ilvCsa, ilVEsa, hisGsa, ureAsa and
MGsa that was probed with 2.5 MCy3-labelled Qrr1 (right). The probed
array has been false-coloured red to match the key. (C) A DNA template
array of MicAsa, Qrr1sa, DsrAsa, RprAsa, hapRsa, ompAsa, rpoSsa and
MGsa templates (left: schematic of a single-field) was used to generate an
eight-RNA array of MicAsa, Qrr1sa, DsrAsa, RprAsa, hapRsa, ompAsa,
rpoSsa and MGsa that was probed with 20 M malachite green (right).
The probed array has been false-coloured cyan to match the key. DNA
template arrays of repeating 4 × 5 grids (A and B) or 4 × 4 grids (C) were
prepared using an automated arrayer with individual spots separated by
1250 m. Probed RNA images have all been mirror imaged so that the
spot positions correspond to those shown in the schematic of the DNA
template arrays.
Production and applications of high-density multi-RNA ar-
rays
Having successfully generated a high-density RNA array of
identical RNAmolecules, we wanted to expand ourmethod
to the fabrication of high-density multi-RNA arrays. Fur-
thermore, we wanted to demonstrate the potential of these
arrays as a high-throughput screening platform for RNA-
based interactions.
In order to demonstrate utility to RNA–RNA interac-
tion screening, high-density eight-RNA arrays were pre-
pared. These arrays were probed with either MicA-specific
ompA or Qrr1, an sRNA that binds to and regulates the
expression of hapR mRNA (30,31; Supplementary Figure
S3B). The ompA RNA probe correctly discriminated be-
tween MicA and seven other RNAs (Figure 5A). Similarly,
the Qrr1 probe specifically bound hapRsa in the context of
seven other RNAs (Figure 5B). In addition, to demonstrate
the application of functional-RNA arrays to RNA–small
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molecule interactions, Figure 5C shows the small molecule
malachite green correctly discriminating betweenMGsa and
seven other RNAs.
We next attempted simultaneous probing of multi-RNA
arrays using multiple probes. Supplementary Figure S5
shows the generation of a RNA array containing MicAsa
and hapRsa, simultaneously probed with two RNAs: ompA
and Qrr1. In addition to simultaneous screening of multi-
ple RNA–RNA interactions, it is possible to simultaneously
screen both RNA–RNA and small molecule–RNA interac-
tions. A high-density four-RNA array containing MicAsa,
hapRsa, MGsa and ompAsa was produced (Figure 6A and
B). This was simultaneously probed with Qrr1 and mala-
chite green (Figure 6C). The probed spots measured 151 ±
21 m and 300 ± 98 m FWHM, for malachite green and
Qrr1 respectively (Figure 6D).
These multi-RNA array experiments are examples of the
application of functional-RNA arrays to screening sets of
diverse RNAs. However, it may also be useful to screen a
series of RNAs that differ by only a single nucleotide. Pro-
vided that the nucleotide substitutions occur within the in-
teracting region, using appropriate probing conditions, it
should be possible to observe a correlation between the the-
oretical Gibbs free energy (G) of the interaction and the
fluorescence intensity of the probe. To demonstrate this,
we selected the interaction between hapR and Qrr1. The
theoretical G of the interaction between the wild-type
hapR and Qrr1 was calculated using Mfold (17) to be –
18.3 kcal/mol (Supplementary Figures S3B and S6A). For
a hapRmutant, hapR(G63C), known to disrupt hapR:Qrr1
pairing (31), the theoretical G of the interaction was cal-
culated to be –10 kcal/mol (Supplementary Figure S6A).
An RNA array consisting of hapRsa, hapR(G63C)sa and
hapR(C64G)sa, a hapR variant resulting in a theoretical
hapR:Qrr1 G of –14.2 kcal/mol (Supplementary Figure
S6A), was generated and probed with Qrr1. As shown in
Supplementary Figure S6B, there is a clear correlation be-
tween the fluorescence intensity of the Qrr1 probe and the
calculated theoretical G for the hapR:Qrr1 interaction.
Therefore, it is possible to detect single nucleotide substi-
tutions with functional-RNA arrays.
DISCUSSION
Here we have demonstrated an innovative method for the
production of high-density arrays of functional RNAs that
involves the surface-capture of in vitro transcribed RNAs
(Figure 1). Each of the RNAs examined was transcribed
from the bacteriophage T7 promoter using a commercially
available T7 in vitro transcription kit. However, we see no
reason why the method could not be adapted for other tran-
scriptions systems, including those of eukaryotic origin. To
facilitate surface-capture, an RNA aptamer was conjugated
to the 3′ end of the RNA of interest.We evaluated the use of
tobramycin and streptavidin aptamers, although other ap-
tamers could be employed. We found that the streptavidin
aptamer was the most versatile. For some RNAs, we ob-
served non-specific binding to the tobramycin on the cap-
ture surface, a known problem with tobramycin at physio-
logical pH (25). Using this system, we investigated RNAs
ranging in size from 38 nucleotides (the malachite green ap-
tamer) to 606 nucleotides (the 5′ UTRof rpoSmRNA),with
several in the 75–200 nucleotide range (e.g. MicA sRNA:
75 nucleotides; the 5′ UTR of ompA mRNA: 167 nt). This
size range encompasses many prokaryotic, eukaryotic and
viral RNAs of functional interest, as well as biotechno-
logically relevant synthetic RNAs such as aptamers, and
we envisage that longer RNAs could be produced, if re-
quired. The functional-RNA arrays were probed with ei-
ther a small-molecule that fluoresces upon RNA-binding
or a fluorescently-labelled RNA binding partner. However,
a wide-range of probes could be used, including protein,
DNA, RNA and small molecules.
Our production method has significant advantages over
previously reported technologies. Firstly, the physical sep-
aration of the DNA template and RNA capture surfaces
simplifies the final RNA surface, relative to those in the
methods based on the Illumina Next Generation Sequenc-
ing platform (11–14). The Smith group achieved a simpli-
fied surface by nuclease treatment (15,16). However, the use
of chemically synthesized in vitro transcription templates
in their photolithography-based method, limited the size of
the RNAs that could be generated. An additional benefit of
our method over both of the currently available platforms is
the 3′-tethering of the RNA to the capture surface. The con-
jugation of an aptamer to the 3′ end of the RNA of interest,
to facilitate surface-immobilization, ensures that only full-
length, correctly folded RNAs are captured.
The advantage of RNA-based tethering, to produce a
simpler RNA surface, combined with the ability to immo-
bilize full-length functional RNAs expands the utility of
multi-RNA platforms. To-date, applications have focused
solely on RNA–protein interactions. The Illumina-based
approaches, which retain the DNA template on the ‘RNA’
surface, are unsuitable for studying primarily sequence-
driven RNA–RNA interactions and the length-limitations
of the photolithography method exclude the investigation
of interactions relying on a global structure such as RNA–
small molecule interactions.We have now demonstrated the
proof-of-principle application of high-density functional-
RNA arrays to the investigation of RNA–RNA and RNA–
small molecule interactions. Furthermore, our method is
more accessible than the existing technologies, both of
which require specialist equipment. Preparation of the high-
density RNA arrays does require access to an automated
arrayer. However, low/medium-density arrays can easily be
prepared and probed using standard laboratory equipment.
In demonstrating the application of our functional-RNA
arrays to the study of RNA–RNA interactions we have fo-
cused on bacterial non-coding small regulatory RNAs (sR-
NAs). sRNAs act by imperfect base-pairing to an mRNA
target, typically within the 5′ UTR, modulating translation
initiation and/or transcript stability (3,32). Through this
mechanism they regulate genes involved in diverse cellular
processes, including bacterial virulence (6). Consequently,
sRNA–mRNA interactions are of interest in developing
novel antimicrobials (10). Here we have shown that the pre-
viously reported MicA–ompA (26) and Qrr1–hapR (30,31)
interactions can be specifically detected using out technol-
ogy. Both of these interactions are of potential pharmaceu-
tical interest, with ompA an essential gene and, therefore, an
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Figure 6. Simultaneous screening of a high-density multi-RNA array with multiple probes. (A) Schematic of a DNA template array of repeating 4 × 4
grids of MicAsa, hapRsa, MGsa and ompAsa templates that was prepared using an automated arrayer with individual spots separated by 1250 m. (B)
The generated four-RNA array of Cy3-labelled MicAsa, hapRsa, MGsa and ompAsa. (C) A non-labelled MicAsa, hapRsa, MGsa and ompAsa RNA array
(generated as in (B) but without labelling) probed with 3 MCy3-labelled Qrr1 and 20 Mmalachite green. The labelled (B) and probed (C) RNA array
images have been mirror imaged so that the spot positions correspond to those shown in the schematic of the DNA template array (A). (D) Spot profiles
for the first two rows of the probed RNA array shown in (C). The red and green lines are the spot profile data for malachite green and Qrr1, respectively.
The dashed black lines are the least-squares minimization of a function describing the sum of two co-incident Gaussian distributions (one for the main
peak, and one for weak signal broadening due to diffusion of non-specifically bound probe):- f (x) =
2∑
i=1
ai exp
(
− (x−μi)2
2σ 2i
)
where f (x) is the fluorescence
intensity at position x, and ai , μi and σi are the intensity, centre and standard deviation, respectively, of spot i. The FWHM for each spot was calculated
as:- FWHM = 2σ√2 ln 2.
antimicrobial target (33) and theQrr1–hapR interaction im-
plicated in V. cholerae virulence (30,31). We anticipate that
the functional-RNA array platform will be used to charac-
terize the complex networks of sRNA–mRNA interactions
that exist in vivo and in the screening of potential antimicro-
bial mimics or modulators of these systems.
Although we demonstrate the application of our technol-
ogy to non-coding bacterial sRNAs, there are equivalent eu-
karyotic RNA-based systems (miRNA and siRNA (4,34))
that could also benefit from the functional-RNA array plat-
form. For example, miRNAs are key players in cell differ-
entiation, proliferation and survival, and dysregulation of
miRNA activity is implicated in many cancers, cardiovas-
cular disease and diabetes (7). Mapping of miRNA net-
works to identify therapeutic targets would be a potential
application of the RNA array platform. Furthermore, an-
tisense oligonucleotides (ASOs) or siRNAs are an attrac-
tive strategy for artificially controlling eukaryotic mRNA
expression (9). However, efforts to use mRNA-targeting
ASOs and siRNAs therapeutically have been hampered by
unconvincing/inaccurate data, often the result of off-target
effects due to non-specific protein binding or partial com-
plementarity to unintended targets (35). Using the RNA
array platform as a screening tool could help to identify
and/or circumnavigate potential problems much earlier in
the drug-discovery process.
In addition, by using protein synthesis as a read-out,
the RNA array platform has scope for use in post-
transcriptional regulation assays. These assays would be ap-
plicable to the non-coding RNA systems discussed above,
small molecule–RNA-based systems (e.g. riboswitches (2))
and the development of synthetic modules based on sR-
NAs (e.g. toehold switches (36)), or riboswitches (37), which
would be of use to the synthetic biology and biotechnol-
ogy fields. Alternatively, the platform could find utility as
a biosensor, particularly for the detection of RNA viruses
(38,39).
Overall, we have demonstrated a simple, novel method
for the production and application of the first functional-
RNA arrays that has significant advantages over previously
reported technologies improving accessibility of RNA ar-
ray platforms to the RNA research community. More im-
portantly, our method is uniquely suitable for the investiga-
tion of RNA–RNA and RNA–small molecule interactions.
OurRNAarrays have true platform technology capabilities,
with broad potential applications in the non-coding RNA,
post-transcriptional gene regulation and biosensor fields.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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